Hemispherx Biopharma, Inc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (33)

Latest Posts

About This Stock More About This Stock
Depomed To Acquire U.S. Rights To NUCYNTA®, NUCYNTA® ER; Amgen Presents First-Line Use Of Vectibix®
Article By: BioMedReports
Friday, January 16, 2015 3:44 AM EDT
Depomed Inc. announced it has entered into a definitive agreement to acquire the U.S. rights to the NUCYNTA franchise from Janssen Pharmaceuticals, Inc. for $1.05 billion.
In this article: DEPO, AMGN, DDD, ADXS, ALDX, AMBS, AMED, BSDM, BMRN, CBMG, DVCR, GALE, GB, HTBX, HEB, ISRG, OMED, PMCB, PRGB, RGDX, TGTX, WCUI
Read
Biotech Investors Gamble On Ebola Stocks
Article By: BioMedReports
Tuesday, October 7, 2014 6:39 AM EDT
The recent outbreaks of Ebola in Africa and the first case found in the U.S. have also heightened the FDA’s awareness of disease outbreaks and the need for stronger safety measures, but nothing gets investors salivating more than constant media attention.
In this article: HEB, INO, TPIV, TKMR
Read
E “New Frontier Stocks” At Play In The Battle Against Ebola
Article By: M.E. Garza
Sunday, October 5, 2014 10:34 AM EDT
Several public companies have thrown their hats into the Ebola pandemic conversation, but only some will perform well for investors day in and day out.
In this article: HEB, INO, TPIV, TKMR
Read
Morning Call For Oct. 1, 2014
Article By: Jim Van Meerten
Wednesday, October 1, 2014 9:32 AM EDT
December E-mini S&Ps (ESZ14 -0.14%) this morning are down -0.10% and European stocks are down -0.09% after a gauge of Eurozone manufacturing activity last month was revised lower to its slowest pace of expansion in 15 months.
In this article: AGN, DF, FCX, JNS, LMT, TSN, HEB, EBAY, PNRA
Read

PARTNER HEADLINES

Latest Tweets for $HEB

No tweets yet!